Kute Vivek, Varugese Santosh, Prasad Narayan, Shroff Sunil, Agarwal Sanjay Kumar
Department of Nephrology, Institute of Kidney Diseases and Research Center, Dr HL Trivedi Institute of Transplantation Sciences [IKDRC-ITS], Ahmedabad, Gujarat, India.
Department of Nephrology, CMC Vellore, Tamil Nadu, India.
Indian J Nephrol. 2020 May-Jun;30(3):176-178. doi: 10.4103/ijn.IJN_221_20. Epub 2020 Jun 10.
Development of COVID-19 pandemic has affected organ transplant activity significantly. To start with, government of India had adviced stoppage of "elective" surgeries so as to cope with resources and manpower for COVID-19 patients. As majority of hospitals are having both COVID and Non-COVID patients, there is obvious fear of cross-infection. Also, transplant patients being immunocompromised, there is higher risk of acquiring COVID-19 infection along with atypical presentation and unpredicted course of the disease. Result was that across India, elective living related kidney transplant came to a halt. Cadaver renal transplant, being emergency in nature still done, though very few. With passing time, once it became clear that pandemic is not going to be controlled sooner, need has been felt to restart renal transplant activity. Keeping various issues in mind in relation to elective living related renal transplant and emergency deceased donor renal transplant, these guidelines have been framed to help transplant professionals for restarting renal transplant program again in the country, while keeping both health care workers and patient safe.
新冠疫情的发展对器官移植活动产生了重大影响。首先，印度政府建议停止“择期”手术，以便为新冠患者调配资源和人力。由于大多数医院都同时收治新冠患者和非新冠患者，交叉感染的担忧显而易见。此外，移植患者免疫功能低下，感染新冠病毒的风险更高，且症状不典型、病程难以预测。结果是，全印度的择期亲属活体肾移植陷入停滞。尸体肾移植由于性质紧急仍在进行，不过数量极少。随着时间推移，一旦明确疫情短期内无法得到控制，重启肾移植活动的需求便凸显出来。考虑到与择期亲属活体肾移植和紧急脑死亡供体肾移植相关的各种问题，制定了这些指南，以帮助移植专业人员在保障医护人员和患者安全的同时，在该国重新启动肾移植项目。
